Proof Before Scale
Overview
A commercial-stage precision diagnostics company that develops molecular diagnostic tests for urological cancers and other urologic diseases wanted to explore digital marketing but wasn't ready to commit to a large investment without first demonstrating measurable business value.
DigiVidBio designed a strategic pilot campaign that minimized risk while maximizing learning.
By combining precision NPI targeting with a built-in control group, the client quickly proved marketing ROI, earned organizational confidence, and successfully expanded the program into an ongoing commercial initiative.
● Proof Before Scale - Validated marketing performance before expanding investment.
● Control Group Validation - Measured true campaign impact against untreated providers.
● Budget Doubled Mid-Pilot - Strong early results gave leadership the confidence to increase investment.
● Budget Doubled Mid-Pilot - Strong early results gave leadership the confidence to increase investment.
Target Audience
Healthcare Providers Familiar with the Diagnostic Test
- The campaign focused on physicians who already knew the product but had not recently ordered the diagnostic test.
Commercial Marketing Leadership
- Product marketers seeking measurable ways to demonstrate marketing value while reducing investment risk.
The Challenge
How Do You Build Confidence in a New Marketing Strategy?
Start Smart, Not Small
- The product marketing team believed digital marketing could accelerate growth but recognized that securing a large initial investment would require evidence—not assumptions. Rather than asking leadership to take a leap of faith, they wanted a practical way to prove the concept first.
Measure Real Business Impact
- The product marketing team believed digital marketing could accelerate growth but recognized that securing a large initial investment would require evidence—not assumptions. Rather than asking leadership to take a leap of faith, they wanted a practical way to prove the concept first.
Create a Scalable Growth Plan
- The product marketing team believed digital marketing could accelerate growth but recognized that securing a large initial investment would require evidence—not assumptions. Rather than asking leadership to take a leap of faith, they wanted a practical way to prove the concept first.
The Solution
Proof Before Scale
Instead of launching a large campaign, DigiVidBio developed a carefully structured pilot that minimized financial risk while maximizing measurable insight.
Precision NPI targeting, provider-level engagement reporting, and a matched control group created a framework that could objectively validate marketing performance before recommending broader investment.
Precision Audience Selection
Focused on healthcare providers already familiar with the diagnostic test but who had not recently ordered it, maximizing the likelihood of measurable behavior change.
Control Group Measurement
Created matched test and control audiences to isolate the true impact of marketing on diagnostic ordering behavior.
Continuous Optimization
Refreshed creative messaging throughout the campaign to identify which messages generated the strongest provider engagement.
Map Targeted NPIs to Diagnostic Orders
Measure the revenue impact on the business by mapping orders to the targeted NPIs in the campaign and in the control group.
Strategic Approach
Reduce Risk. Increase Confidence. Scale with Evidence.
Reduce Risk. Increase Confidence. Scale with Evidence.
Focused on
The pilot wasn't designed simply to generate impressions—it was built to answer critical business questions about audience behavior, marketing effectiveness, and return on investment before larger commitments were made.
Build Organizational Confidence
Built For
Objective performance measurement gave marketing leadership the evidence needed to secure additional investment and transform a pilot campaign into a long-term commercial strategy.
Execution
From Pilot Program to Proven Growth Engine
- Launched a six-month NPI-targeted pilot campaign.
- Created a matched control group to validate true campaign impact and monitored provider engagement and diagnostic ordering behavior.
- Expanded investment after early performance exceeded expectations.
Activated Across
Results
Mid-campaign
BECAUSE PERFORMANCE SPOKE FOR ITSELF
Just over two months into the pilot, results were compelling enough that leadership doubled the campaign budget before the original program had even concluded.
Clear ROI Validation
The comparison between the targeted audience and the control group demonstrated that marketing directly influenced diagnostic ordering behavior.
Expanded Commercial Investment
The success of the pilot led to an additional six-month campaign at the higher investment level.
Ongoing Program Success
The client continues running the campaign because it consistently delivers positive ROI.
Optimized for
Key Takeaway
The Best Way to Earn a Bigger Marketing Budget Is to Remove the Risk
Start with Proof
Well-designed pilot campaigns allow organizations to validate new marketing strategies before committing significant investment.
Measure What Matters
Control groups and provider-level analytics transform marketing from a cost center into a measurable business investment.
Healthcare marketing innovation doesn't require blind faith—it requires evidence. By designing campaigns that prioritize measurable learning alongside measurable performance, this commercial-stage precision diagnostics company transformed a cautious first step into a scalable, long-term marketing program. The Proof Before Scale methodology gave leadership the confidence to expand investment based on objective business results rather than assumptions.
The DigiVidBio Difference
Proof Before Scale
Many healthcare organizations hesitate to adopt new marketing strategies because proving ROI can feel uncertain. DigiVidBio's Proof Before Scale™ methodology reduces that uncertainty by combining precision audience targeting, control-group validation, and provider-level analytics into a structured pilot framework. The result is a marketing strategy that builds organizational confidence through measurable evidence before larger investments are made.
Ready to Prove What's Possible Before You Scale?
Whether you're launching your first digital campaign or testing a new commercial strategy, DigiVidBio helps healthcare organizations reduce risk, validate performance, and build marketing programs that earn long-term investment through measurable results.
Book a strategy call